A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):537-42. doi: 10.1016/s0360-3016(96)00541-x.

Abstract

Purpose: To establish the shortest possible overall treatment time, with respect to acute and late toxicity, in which a radiation dose of 66 Gy in 2 Gy/fraction can be administered to the urinary bladder.

Methods and materials: In a stepwise fashion the overall treatment time of our routinely used conventional treatment schedule (66 Gy in 2 Gy/fraction in 6.5 weeks) was reduced to 5 weeks (Step 1) and then 4 weeks (Step 2). Shortening of the overall treatment time was obtained by giving two daily fractions during the last part of the treatment. The interfraction interval was a minimum of 6 h. Toxicity was scored according to a modified scheme of the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer. Fifteen patients received the 5-week schedule and 25 patients received the 4-week schedule.

Results: Note that feasibility was very good for the 5-week schedule. No Grade > or = 3 acute bowel or bladder toxicity was seen in these patients. Severe late complications did not occur. In the 4-week schedule, acute bladder toxicity was unaffected but acute bowel toxicity was considerably increased. Of the 25 patients, 16 suffered from Grade 3 toxicity, 3 from Grade 4, and 1 from Grade 5 toxicity. Actuarial analysis at 3 years showed a 31% incidence of Grade 4 late bladder complications.

Conclusion: It is concluded that the 5-week schedule is well tolerated. In contrast, the 4-week schedule shows unacceptable acute bowel toxicity and an increased incidence of late bladder complications (p = 0.043).

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Carcinoma, Transitional Cell / radiotherapy*
  • Feasibility Studies
  • Humans
  • Intestines / radiation effects*
  • Middle Aged
  • Radiation Injuries / pathology*
  • Radiotherapy Dosage
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder / radiation effects*
  • Urinary Bladder Neoplasms / radiotherapy*